Navigation Links
Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts
Date:2/23/2011

WOONSOCKET, R.I., Feb. 23, 2011 /PRNewswire/ -- Xenogenics Corporation ("Xenogenics"), a majority owned subsidiary of MultiCell Technologies, Inc. (OTC Bulletin Board MCET), is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation strategy to help finance expanded human clinical trials of its Ideal BioStent™.  

In animal testing and initial human use, the Ideal BioStent™ demonstrated equivalence in safety, short-term efficacy, and structural integrity when compared with today's leading bare metal stents and drug-eluting metal stents.  Unlike other bioabsorbable stent technologies, the Ideal BioStent™ showed no stent recoil, both acute and at six month follow up, remaining well apposed to the vessel wall.  The Ideal BioStent™ is designed to be fully absorbed at 12 months leaving no metal artifact behind, thereby allowing the vessel to heal and return to its natural state.  

The Ideal BioStent™

  • Game changing platform addressing next generation requirements of multi-billion dollar interventional cardiology market.

  • Only platform based on patented bioabsorbable polymer incorporating anti-inflammatory, anti-thrombotic, and anti-neoplastic drugs.

  • Positive human clinical experience – demonstrated comparable radial strength with no stent recoil.

  • Strong, seminal IP position covering key aspects of technology, including drug incorporation directly into polymer chain.

  • Broad technology platform including coronary and peripheral stents.

The multi-billion dollar interventional cardiology and intravascular stent market remains extremely lucrative, and one of the most at
'/>"/>

SOURCE Xenogenics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... TODAY, AEGATE, the leader in medicine verification ... of Peter Fox as Chief Technology Officer ... Officer. Peter has served as Development Director ... Oracle in 2011. Prior to Datanomic, Peter ... and subsequently Convergys, a world renowned billing system for ...
(Date:12/19/2014)... Dec. 19, 2014 Breckenridge Pharmaceutical, Inc. announced ... with MSN Laboratories Pvt. Ltd. ( Hyderabad, India ... commercialize several new ANDAs.  Under the terms of the ... exclusively to Breckenridge for the U.S. market, and Breckenridge ... Breckenridge and MSN have agreed to develop an oral ...
(Date:12/19/2014)... 19, 2014  Monarch America Inc. (OTCQB: CANK) ("Monarch ... pleased to provide this review of the Company,s recent ... "Over this past year, we achieved many ... extremely proud to say that Monarch America is in ... has ever been," stated Eric Hagen , CEO ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3
... , SAN JOSE, ... (CKS), a non-profit organization of medical professionals dedicated to advancing ... that its 2010 CyberKnife Society Scientific Meeting will be held ... downtown Dallas, Texas .   , The CyberKnife Society ...
... BOCA RATON, Fla. , Feb. 18 ... electronic medical records management, announced today the addition of Mr. ... Advisors. , CEO of Boston -based O,Neill and Associates, ... the highly respected and vastly influential government relations and communications ...
Cached Medicine Technology:CyberKnife Society Scientific Meeting to Highlight Clinical Results and Technical Innovations 2CyberKnife Society Scientific Meeting to Highlight Clinical Results and Technical Innovations 3Government Relations CEO Joins MedeFile Advisory Board 2Government Relations CEO Joins MedeFile Advisory Board 3Government Relations CEO Joins MedeFile Advisory Board 4
(Date:12/22/2014)... (PRWEB) December 22, 2014 The MedTech industry ... Inc, a wholly owned subsidiary of PartnerTech AB of Sweden, ... having recently achieved additional ISO Certification. , All signs point ... employment and the likelihood of a repeal of the excise ... . The industry is anticipating annual growth of 9.3% and ...
(Date:12/22/2014)... December 22, 2014 7,178 small business ... of Black Friday shopping and opted instead to join ... education company, for their 5th annual “Black Friday Boot ... just $7 to attend the 5 hour online training ... promptly donated to support two Central Texas based charities ...
(Date:12/22/2014)... Christmas is days away, and last minute gifts ... solution that will please: the Sublime Gift Card . ... $25 up to $350," says Kathy Heshelow, founder of ... wide array of skin care products and Skin Brushes." , ... , Gift delivery past shipping deadlines, or those last ...
(Date:12/22/2014)... OAK BROOK, Ill. (PRWEB) December 21, 2014 ... receive radiologist recommendations for chest computed tomography (CT) ... have clinically relevant findings, including cancer, according to ... Radiology. , Researchers said the findings show ... chest X-rays represent valuable contributions to patient care. ...
(Date:12/22/2014)... December 22, 2014 Parker & Sons, ... best in Arizona home contracting services reports a record ... its quality services in 2014. As a company that ... early 1970s, Parker and Sons is a business that ... company works side-by-side with other top quality companies in ...
Breaking Medicine News(10 mins):Health News:PartnerTech Inc. Poised for Growth in MedTech 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3
... 18 Taking Control of Your Diabetes,(TCOYD) announced ... national,research firm Yankelovich that found that more than ... think that excess weight has a positive effect ... overweight often contributes,to the development of diabetes, complicates ...
... Cross asks you to help save lives by donating ... is being held on Saturday, February 21, 2009 from ... Koerner of Sewell, New Jersey. To make an ... (1-800-448-3543). (Logo: http://www.newscom.com/cgi-bin/prnh/20081216/DC52619LOGO )Koerner is battling a ...
... contest for children K-5TULSA, Okla., Feb. 18 There ... sixth annual Be Smart--Don,t Start! storyboard contest, ... of tobacco use. Request free contest materials and information ... be postmarked by Feb. 27.Sponsored by the American Lung ...
... 2009 Takeda Pharmaceutical Company Limited and its wholly-owned ... the United States Food and Drug Administration (FDA) has ... the chronic management of hyperuricemia in patients with gout. ... option in more than 40 years for the more ...
... the journal Nature Genetics have for the ... heart attack and coronary heart disease. In one of ... kind, the Myocardial Infarction Genetics Consortium identified nine precise ... three of them newly discovered; the investigators said that ...
... to be an international leader in personalized medicine and ... of Canadians and to reap the benefits of job ... http://www.cmaj.ca/cgi/rapidpdf/cmaj.1090199 released online today in CMAJ ( Canadian ... based on an individual,s genetic and health needs, rather ...
Cached Medicine News:Health News:One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease 2Health News:One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease 3Health News:Blood Drive Held in Honor of Sewell, NJ Resident - Ellie Koerner 2Health News:Last Chance! Be Smart--Don't Start! Entries Due by Feb. 27 2Health News:FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout 2Health News:FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout 3Health News:New genomic markers associated with risk of heart disease and early heart attack 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: